Analysis of the risk factors of patients with acute coronary syndrome sufferin hemorrhage during hospitalization

Chinese Journal of Cardiology

Volumn 40, Issue 11, 2012, Pages 902-907

  Liu, Xin ^a   Chen, Yun Dai ^b   Lü, Shu Zheng ^a   Jin, Ze Ning ^a   Liu, Hong ^a   Song, Xian Tao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Coronary disease; Hemorrhage; Risk factors

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; RANDOM SAMPLE; SCREENING; UNIVARIATE ANALYSIS;

EID: 84871132738     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2012.11.002     Document Type: Article

References (16)

1. Rao S V, O'Grady K, Pieper K S, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol, 2005, 96: 1200-1206.
2. Manoukian S V. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol, 2009, 104(5 Suppl): 9C-15C.
3. 2007, 24: 14-17.
4. Steg P G, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J, 2011, 32: 1854-1864.
5. 2007, 35: 308-311.
6. 2010, 38: 1057-1059.
7. Shalev A, Zahger D, Novack V, et al. Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int J Cardiol, 2012, 157: 386-390.
8. McCol1um M, Stringer K A, Wittkowsky A K, et al. Discrepancies in identification of bleeding events after percutaneous coronary Intervention. Pharmacotherapy, 2007, 27: 36-40.
9. Santopinto J J, Fox K A, Goldberg R J, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart, 2003, 89: 1003-1008.
10. Kontny F. Improving outcomes in acute coronary syndromes-the FRISC II trial. Clin Cardiol, 2001, 24(3 Suppl): 13-17.
11. Kugelmass A D, Sadanandan S, Lakkis N, et al. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18. Oil Pathw Cardiol, 2006, 5: 167-172.
12. Patti G, Nusca A. Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding. Am J Cardiovasc Dis, 2011, 1: 255-263.
13. Marczewski M M, Postula M, Kosior D, et al. Novel antiplatelet agents in the prevention of cardiovascular complications-focus on ticagrelor. Vasc Health Risk Manag, 2010, 6: 419-429.
14. De Luca G, Suryapranata H, Stone G W, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis ofrandomized trials. JAMA, 2005, 293: 1759-1765.
15. Boersma E, Harrington R A, Moliterno D J, et al. Platelet glycoprotein II b/III a inhibitors in acute coronary syndromes. Lancet, 2002, 360: 342-343.
16. Mahla E, Suarez T A, Bliden K P, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv, 2012, 5: 261-269.